We first analyzed the CD34 + CD38− (i.e., LSC) subpopulation in the KG1 and U937 AML cell lines by qRT–PCR, LSC-associated and ABCB1 gene expression and flow cytometry. This evidence concerns the gene CD34 and acute myeloid leukemia.